Guy Krippner
29Patents
6h-index
35Co-inventors
69Inventor score
Filing activity: Jan 11, 1999 → Jan 17, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6680054B1 | Macromolecular neuraminidase-binding compounds | Physics | 50 | Expired |
| US7166604B2 | Antiviral agents | Emerging Cross-Sectional Technologies | 41 | Expired |
| US6242582A | Method of detection of influenza virus and compounds for use therein | Physics | 28 | Expired |
| US7078403B1 | Antiviral agents | Chemistry; Metallurgy | 27 | Expired |
| US7619091B2 | 8-hydroxy quinoline derivatives | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8586705B2 | Macromolecular compounds having controlled stoichiometry | Human Necessities | 6 | Active |
| US7579465B2 | Antiviral agents | Emerging Cross-Sectional Technologies | 3 | Active |
| US7829705B2 | Antiviral agents | Emerging Cross-Sectional Technologies | 3 | Active |
| US8975278B2 | 8-hydroxy quinoline derivatives | Emerging Cross-Sectional Technologies | 2 | Active |
| US8703116B2 | Modified macromolecule | Chemistry; Metallurgy | 2 | Active |
| US8217171B2 | Antiviral agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US8337823B2 | Modified macromolecule | Chemistry; Metallurgy | 2 | Active |
| US7951955B2 | Antiviral agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US8420067B2 | Targeted polylysine dendrimer therapeutic agent | Human Necessities | 1 | Active |
| US9127130B2 | Polylysine dendrimer contrast agent | Chemistry; Metallurgy | 1 | Active |
| US8455432B2 | Insulin sensitisers and methods of treatment | Human Necessities | 1 | Active |
| US8624025B2 | Antiviral agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US8258259B2 | Macromolecular compounds having controlled stoichiometry | Human Necessities | 1 | Active |
| US7371755B1 | Antiviral agents | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9452148B2 | Insulin sensitisers and methods of treatment | Human Necessities | 1 | Active |
| US10736853B2 | Milrinone controlled-release formulation | Human Necessities | 0 | Active |
| US10517833B2 | Uses of milrinone controlled-release formulation | Human Necessities | 0 | Active |
| US10537527B2 | Milrinone controlled-release formulation | General | 0 | Revoked |
| US9169211B2 | 8-hydroxy quinoline derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US10172837B2 | Insulin sensitisers and methods of treatment | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.